MTM Regulatory Compliance & Ethical Standards 2 — Questions and Answers
Question 1: Under HIPAA's minimum necessary standard, which practice is most appropriate when sharing patient medication information?
- Share all available medication history with any requesting provider
- Disclose only the information reasonably necessary to accomplish the intended purpose (Correct answer)
- Require written authorization for all disclosures to other healthcare providers
- Provide complete PHI whenever treatment continuity is cited as the reason
Correct answer: Disclose only the information reasonably necessary to accomplish the intended purpose
HIPAA's minimum necessary standard requires covered entities to limit PHI disclosures to only what is reasonably necessary for the specific purpose.
Question 2: A pharmacist conducting MTM discovers a patient is using a medication for an off-label indication not supported by evidence. The prescriber insists on continuing. What is the pharmacist's primary ethical obligation?
- Refuse to dispense the medication until evidence-based indication is confirmed
- Document the concern, counsel the patient on risks, and respect the prescriber's clinical judgment (Correct answer)
- Report the prescriber to the state board of pharmacy immediately
- Override the prescription and substitute an evidence-based alternative
Correct answer: Document the concern, counsel the patient on risks, and respect the prescriber's clinical judgment
Pharmacists must document concerns, educate the patient, and collaborate with prescribers while respecting clinical autonomy unless clear harm is evident.
Question 3: Which federal law specifically established the legal framework for Medicare Part D Medication Therapy Management programs?
- Health Insurance Portability and Accountability Act of 1996
- Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Correct answer)
- Affordable Care Act of 2010
- Drug Quality and Security Act of 2013
Correct answer: Medicare Prescription Drug, Improvement, and Modernization Act of 2003
The Medicare Modernization Act of 2003 (MMA) created Medicare Part D and mandated MTM programs for targeted beneficiaries.
Question 4: A patient refuses a recommended medication change during MTM despite documented risks. How should the pharmacist proceed?
- Override the patient's refusal citing professional responsibility
- Document the refusal, ensure the patient understands the risks, and respect patient autonomy (Correct answer)
- Withhold MTM services until the patient agrees to follow recommendations
- Contact the patient's family to obtain consent on their behalf
Correct answer: Document the refusal, ensure the patient understands the risks, and respect patient autonomy
Patient autonomy is a core ethical principle; pharmacists must document refusals and ensure informed decision-making but respect the patient's right to refuse.
Question 5: Which element is required in a Comprehensive Medication Review (CMR) under CMS Medicare Part D MTM guidelines?
- In-person visit with the patient's primary care physician present
- An interactive, real-time consultation with the patient or caregiver (Correct answer)
- Submission of a written questionnaire to the patient before the visit
- Review limited to chronic disease state medications only
Correct answer: An interactive, real-time consultation with the patient or caregiver
CMS requires CMRs to be interactive, real-time consultations conducted with the patient and/or caregiver, not asynchronous questionnaires.
Question 6: Which ethical principle is MOST directly violated when a pharmacist accepts gifts from a pharmaceutical manufacturer in exchange for preferentially recommending their MTM-enrolled products?
- Beneficence
- Non-maleficence
- Justice
- Fidelity (Correct answer)
Correct answer: Fidelity
Fidelity requires loyalty and keeping professional commitments; accepting gifts that bias recommendations breaches the duty of loyalty owed to patients.
Question 7: Under CMS MTM eligibility criteria, a Part D plan sponsor must target beneficiaries who meet thresholds related to which three factors?
- Age, income level, and geographic location
- Multiple chronic diseases, multiple Part D drugs, and likely to incur annual drug costs above a threshold (Correct answer)
- Polypharmacy, hospitalization history, and non-adherence rates
- Medicare/Medicaid dual eligibility, low income subsidy status, and high-risk medications
Correct answer: Multiple chronic diseases, multiple Part D drugs, and likely to incur annual drug costs above a threshold
CMS requires Part D plans to target MTM to beneficiaries with multiple chronic diseases, multiple Part D covered drugs, and expected drug costs above a CMS-set threshold.
MTM Regulatory Compliance & Ethical Standards 2
Under HIPAA's minimum necessary standard, which practice is most appropriate when sharing patient medication information?